Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 15;182(10):6121-8.
doi: 10.4049/jimmunol.0803646.

Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner

Affiliations

Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner

Lauren W Collison et al. J Immunol. .

Abstract

Regulatory T cells (T(reg)) are believed to suppress conventional T cell (T(conv)) proliferation in vitro in a contact-dependent, cytokine-independent manner, based in part on experiments in which T(reg) and T(conv) are separated by a permeable membrane. We show that the production of IL-35, a novel inhibitory cytokine expressed by natural T(reg), increases substantially following contact with T(conv). Surprisingly, T(reg) were able to mediate potent suppression of T(conv) across a permeable membrane when placed in direct contact with T(conv) in the upper chamber of a Transwell plate. Suppression was IL-35 and IL-10 dependent, and T(conv) activation was required for maximal potentiation of T(reg) suppression. These data suggest that it is the induction of suppression, rather than the function of T(reg) that is obligatorily contact dependent.

PubMed Disclaimer

Figures

Figure 1
Figure 1. IL-35 and, to a lesser extent, IL-10 expression is potentiated by contact with Tconv
Tconv or Treg cells from the spleens and lymph nodes of Foxp3gfp, C57BL/6, Ebi3−/−, or Il10−/− mice were purified by FACS. (A) RNA was extracted and cDNA generated from Foxp3gfp Tconv and Treg, alone or from co-cultures (re-sorted based on GFP expression), and from Tconv:Treg co-cultures re-sorted based on differential Thy1 markers. Relative mRNA expression was determined by quantitative real-time PCR from the populations and conditions indicated; unstimulated, stimulated for 48 h with anti-CD3/CD28, and/or cultures containing both Tconv and Treg cells . (B) Supernatants were collected from purified Tconv or Treg cells under indicated conditions and IL-10 secretion measured using Luminex™ technology. (C) Relative Ebi3 (left panel) and Il12a (right panel) mRNA expression of the Tconv and Treg populations indicated using the same experimental approach described in (A). (D) Purified Treg in the absence or presence of Tconv were cultured for 72 h with anti-CD3/CD28. Supernatant was collected for overnight IP with an anti-Il12a (p35) mAb, eluted proteins resolved on an SDS-PAGE gel and blotted with anti-Ebi3 mAb. Data represent the mean ± SEM of (A) 3–8, (B) 6 and (D) 4 independent experiments. Statistical analysis: *p< 0.05, ** p< 0.01.
Figure 2
Figure 2. Treg mediated suppression is potentiated by Tconv cell contact in an IL-10- and IL-35-dependent, but not IL-2, manner
Tconv or Treg cells from the spleens and lymph nodes of C57BL/6, Ebi3−/−, Il12a−/− and Il10−/− mice were purified by FACS. (A) Cells assayed for regulatory capacity (Tconv or Treg alone or in combination at a 4:1 Tconv: Treg ratio) were cultured in the top chambers of a Transwell™ culture plate as indicated. Freshly purified wild-type “responder” Tconv were cultured in the bottom chamber of the 96-well flat bottom plates in medium containing anti-CD3/anti-CD28-coated latex beads. After 64 h in culture, top chambers were removed and [3H]-thymidine was added directly to the responder Tconv cells in the bottom chambers of the original Transwell™ plate for the final 8 h of the 72 h assay. Cultures were harvested and cpm determined. (B) Purified Treg cells from wild-type, Ebi3−/− and Il10−/− mice were cultured at the indicated ratios with purified Tconv and assayed for regulatory capacity in the top wells of the Transwell™ plate. In parallel, Treg were assayed for regulatory capacity when Treg were in direct contact with responder Tconv in the bottom chamber of the Transwell™ plate. Suppression of purified responder Tconv cells was measured by [3H]-thymidine incorporation. (C) RNA was extracted from cells in the bottom chamber of the Transwell™ plate. Groups analyzed were those cultured with no cells in the top chamber or WT Tconv co-cultured with Treg (WT, Il10−/−). IL-2 expression was determined by real-time quantitative PCR. Data represent the mean ± SEM of (A) 4, (B) 2, (C) 2 and independent experiments. Statistical analysis: *p< 0.05. Counts per minute of Tconv cells activated alone, in the absence of any suppressors, were 25,000 – 60,000.
Figure 3
Figure 3. Regulatory capacity of fresh and pre-activated fixed Treg
Tconv or Treg cells from the spleens and lymph nodes of C57BL/6, Ebi3−/−, and Il10−/− mice were purified by FACS. Cells were cultured fresh or pre-activated for 24h prior to culture, with or without fixation with 20% formaldehyde. Cells assayed for regulatory capacity (Tconv or Treg alone or in combination at a 4:1 Tconv:Treg ratio) were cultured in (A) direct contact with responder Tconv in a 96-well round bottom plate. Statistical analysis indicates fixation does not affect the ability of pre-activated Treg to suppress while in direct contact with responder Tconv (B) top chambers of a Transwell™ culture plate as indicated. Freshly purified wild-type “responder” Tconv were activated in the bottom chamber of the 96-well plates. After 64 h in culture, top chambers were removed and [3H]-thymidine was added directly to the responder Tconv cells in the bottom chambers of the original Transwell™ plate for the final 8 h of the 72 h assay. Cultures were harvested and cpm determined. Statistical analysis: *p< 0.05.
Figure 4
Figure 4. Treg mediated suppression across the Transwell™ is IL-10 dependent
Purified Treg were assayed for regulatory capacity in conventional Treg and Transwell™ Treg assays in the presence of an IL-10 neutralizing antibody (10µg/ml) or with recombinant IL-10 (100ng/ml) as indicated. Percent suppression was calculated in reference to the activated Tconv control under the conditions indicated. All % suppression to the left of the line was in reference to Tconv without anti-IL-10 or rIL-10 and the reference for % suppression to the right of the line was Tconv with anti-IL-10 or rIL-10, respectively. Data represent the mean ± SEM of 3 independent experiments. Statistical analysis: *p< 0.05. Counts per minute of Tconv cells activated alone, in the absence of any suppressors, were 25,000 – 60,000.
Figure 5
Figure 5. Treg mediated suppression is potentiated, in part, by TCR signals derived from Tconv cell contact
(A) Purified Tconv with or without fixation with 20% formaldehyde were stimulated for 72 h with anti-CD3/CD28-coated beads and assayed for their proliferative capacity by [3H]-thymidine incorporation. (C) Purified Vβ8+ or Vβ8 Tconv were stimulated for 72 h with anti-Vβ8-coated beads and assayed for their proliferative capacity by [3H]-thymidine incorporation. (B and D) Purified Tconv or Treg cells were cultured under indicated conditions; unstimulated, stimulated for 72 h with anti-CD3/CD28-coated beads with or without fixation with 20% formaldehyde (B), or anti-Vβ8-coated beads (D) and assayed for their ability to suppress responder Tconv proliferation across the Transwell™ membrane. Data represent the mean ± SEM of 4–6 independent experiments. Statistical analysis: *p< 0.05. Counts per minute of Tconv cells activated alone, in the absence of any suppressors, were 25,000 – 60,000.
Figure 6
Figure 6. Tsup-derived IL-10 may contribute to the regulatory milieu
Wild-type Treg were cultured with Tconv from wild-type, Ebi3−/− and Il10−/− mice in the top chambers of the Transwell™ plate. The ability of these co-cultures to suppress fresh responder Tconv proliferation in the bottom chamber was measured by [3H]-thymidine incorporation. Data represent the mean ± SEM of 5 independent experiments. Statistical analysis: *p< 0.05, ** p< 0.01. Counts per minute of Tconv cells activated alone, in the absence of any suppressors, were 25,000 – 60,000.

References

    1. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998;10:1969–1980. - PubMed
    1. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol. 2006;7:83–92. - PMC - PubMed
    1. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287–296. - PMC - PubMed
    1. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190:995–1004. - PMC - PubMed
    1. Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, Powrie F. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2005;201:737–746. - PMC - PubMed

Publication types

LinkOut - more resources